Concepedia

Harmen van Andel

HV

Statistics

Publications

9

Citations

620

H-Index

9

Active since

2012

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

University of Amsterdam

Hubrecht Institute for Developmental Biology and Stem Cell Research

University Medical Center Utrecht

Erasmus University Rotterdam

Harmen van Andel is an author at Amsterdam UMC Location University of Amsterdam specializing in cell signaling, cancer cell signaling, and medicine.

ORCID

Publications per year

2012–2017

9

Publications

9

Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling

Jurrit Zeilstra, Sander P.J. Joosten, Harmen van Andel et al. · Oncogene · 2013 · 137 citations

, , +15

NLRX1 dampens oxidative stress and apoptosis in tissue injury via control of mitochondrial activity

Geurt Stokman, Lotte Kors, Pieter J. Bakker et al. · The Journal of Experimental Medicine · 2017 · 112 citations · Full text

, , +17

Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins

Zemin Ren, Harmen van Andel, Wim de Lau et al. · Blood · 2017 · 83 citations · Full text

, , +14

MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms

Sander P.J. Joosten, Jurrit Zeilstra, Harmen van Andel et al. · Gastroenterology · 2017 · 58 citations · Full text

, , +14

Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma

Kinga A. Kocemba‐Pilarczyk, Richard W.J. Groen, Harmen van Andel et al. · PLoS ONE · 2012 · 54 citations · Full text

, , +17

1–5 of 9